AHR levels in tumors predict response to Keytruda and other anti-PD-1 therapies in NSCLC

TECHNIQUES CATEGORY: Biomarkers

TECHNOLOGY: Tissue markers

Tumor levels of AHR could help predict response to Keytruda pembrolizumab

Read the full 152 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE